DHC wrote: . . . Please do not feel the need to "shut up on the subject" - as it seems there was a time (if my read of your past posts is accurate) when you were looking for similar answers.
I'm still looking for answers on many things. Yes. But I may need to shut up before I get on the nerves of those with more experience and more firsthand knowledge on the subject.
DHC wrote: . . . I 'get it' that the manufacturers want us - the end users of the devices they manufacture and sell - to consider the metrics less critically. Use of the data for trend purposes is just that - a less critical examination of the metric. I acknowledge that ANY consistent value produced the same way day in and day out will have benefit for trending purposes, and should allow the user to 'tweak' the settings and hopefully improve the therapeutic benefit of the device.
I'm glad you get the purpose of the data and why it is good enough without being PSG-quality data. That explains why manufacturers are RIGHT in not wanting us, or clinicians, to consider the data more critically--the manufacturers are well aware of the limitations of data based merely on estimates of flow. A lab PSG is a mountaintop astronomy-grade telescope; a home-machine's data is a pair of opera glasses. A lab PSG is an electron microscope, and home-machine data is a drugstore magnifying glass.
Some patients are offended when they talk to the sleep doc about their machine's data and the doc says: "I have no use for home-machine data." I am not offended by that, because from the doc's perspective, the data isn't PSG level and not worthy of being used to make treatment decisions. We can use the data for tweaking, and a big jump in the numbers might catch a doc's attention, but only in the sense that the doc would send the patient for another titration.
What we have to remember is that the purpose of measuring AHI during a diagnostic is mostly just to have something to tell insurance (that the patient has something measurable) and to provide a baseline for the titration AT THE SAME LAB. All that number does, then, is earn the patient the right to try PAP therapy. Plenty of "fudging" of THAT data takes place every day. Then AHI is used to titrate, as well as snoring and other things. BUT not even that lab considers that snapshot to represent the be-all and end-all in diagnosing the patient. Response to treatment gets factored in as well.
So once a patient gets a machine and is titrated, AHI has served its purpose, as far as the medical people are concerned. After that, all that matters is keeping the treatment effective. And that's where home-machine data comes into play. There is no need for it to be very accurate, because the diagnosis and overall titration is over. Now it is a simple matter of answering the question: "Do I increase pressure, lower pressure, or keep it the same?" As long as you have trending data, you have enough info to answer your question. A PSG every night would be overkill, even if you had a sleep lab in your bedroom.
DHC wrote: . . . Implicit in your response is that the vendors have the freedom to define AHI (as collected and output from their reports) any way they want and whether it comports to any published standard is irrelevant. Please correct me if I mis-stated your point.
The fact that they do it proves the freedom. The published standards are for the mountaintop telescopes and electron microscopes, not opera glasses and drugstore magnifying glasses, which distort what they measure and have limited measurement capabilities, but are still very valuable at the opera or when organizing your stamp collection.
DHC wrote: . . . * A device that follows the same standards as used for the PSG (as much as possible) and produces reports that are at least somewhat 'in the ball park.'
There is no such thing. And there is no ballpark. A home-machine's data is stickball over a manhole cover. Still a lot of fun. (Especially the arguments.) But it isn't major-league ball with an experienced set of umpires.
DHC wrote: . . . In this topic, early on, there was one person - a ResMed user - who was quick to draw the conclusion that the S9 is providing superior results to the IntelliPAP. Was that person correct? I don't think so - at least, I am not yet convinced. I remain open-minded, but the DATA suggests something different.
I would tend to trust her judgment in such matters, myself, based on the data put before her, but I wouldn't, of course, let it trump my personal experience in my decision-making for myself on which machine works best for me. And remember, she was discussing indications of the likely efficacy of a particular algorithm with a particular patient (you), and the only real way to know for sure, naturally, is response to treatment in totality, not using home-machine AHI estimates alone. Her pointing out what the data was pointing to was a logical thing to do, since you were asking about the indications from the data. But that doesn't mean she was recommending that the data should be considered more than it is, either.